Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe most useful Mounjaro tip for beginners is also the least glamorous: the first pen is not meant to produce dramatic results, and expecting it to is the single biggest source of early disappointment. Tirzepatide starts at a 2.5mg tolerability dose — the job of that first four weeks is to let your body adjust, not to show the scale moving sharply. Understanding that from day one changes everything. These are prescription-only medicines, and a GPhC-registered prescriber decides whether treatment is clinically suitable for you; but if you've already started, or you're about to, the practical guidance below (drawn from verified UK clinical sources) can make the early weeks considerably easier.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
New starters often interpret a quiet first week as evidence that Mounjaro isn't working for them. It is working, it's just doing a different job. The 2.5mg pen exists because tirzepatide's gastrointestinal effects can be sharp if the dose escalates too quickly; the starter pen settles your system before the medicine starts exerting its full appetite effect. This is well-documented in the tirzepatide prescribing information on the NHS medicines page for tirzepatide, which explains the step-up schedule plainly for patients.
What that means practically: don't calibrate your expectations against week one. Most people notice appetite changes more clearly from 5mg onward, and the trial evidence (including the SURMOUNT-1 study involving thousands of adults with obesity) was measured over 72 weeks, not a fortnight. Give the medicine the time the schedule asks for. Your prescriber decides each dose step; never adjust the timing yourself or skip a rung to try to speed things along.
A question our prescribers hear most weeks: "Should I have felt something by now?" The honest answer is that 2.5mg often produces subtler effects than people anticipate, and that's completely normal. The appetite shift tends to become unmistakable once titration is underway. If you have specific concerns about your progress, that's a conversation for your prescriber, and our Mounjaro tips page covers many of the common early questions people bring to us. You can reach our clinical support team seven days a week if you're a nume patient.
Nausea is the side effect most people have heard about, but the one that catches beginners off guard is fatigue, sometimes noticeable in the 24 to 48 hours after an injection. It tends to be mild and short-lived, but it's worth injecting on an evening you don't have an early start the next morning, at least for the first few weeks. Keep that option in mind rather than locking yourself to a Monday-morning routine before you know how you respond.
The gastrointestinal side effects listed by the NHS (nausea, loose stools, indigestion, burping, constipation) are most common after starting and after each dose increase. Two things help more than most people realise: eating slowly and stopping before you feel full, and avoiding high-fat or very rich meals on injection day. Tirzepatide slows gastric emptying, so fat-heavy food sits uncomfortably for longer than usual. There are good practical ideas in our guide to eating well on Mounjaro if you're finding mealtimes tricky.
Hydration matters more than it sounds. Some of the early fatigue and headache beginners report is partly dehydration, reduced appetite can mean forgetting to drink as well as eat. Aim for water first, and be aware that alcohol can feel considerably stronger than usual because gastric emptying is slower. A small glass goes further. That's not a reason to avoid it entirely, but beginners are regularly surprised by it.
Tirzepatide is injected once weekly, subcutaneously, into the abdomen, thigh, or upper arm. Rotating the site (not returning to the same spot week after week) reduces localised soreness and the small risk of lipohypertrophy over time. Each Mounjaro KwikPen contains four weekly doses; you'll advance the dose counter with each use. The full storage and administration detail lives in the Patient Information Leaflet inside your box; read it before your first injection, not after.
Cold medicine stings more. If your pen has come straight from the fridge, letting it sit at room temperature for 20 to 30 minutes before injecting makes the experience noticeably more comfortable. Check the exact room-temperature storage window in your leaflet, since it differs from what you might remember reading online, and never exceed it. Inject into a clean site using a fresh needle every time, changing needles is both a hygiene requirement and a comfort one, since a needle used more than once is measurably less sharp.
Our overview of how to take Mounjaro correctly covers technique in more detail, including what to do if you notice a missed dose situation. The short answer on missed doses: follow your leaflet and contact your prescriber; don't try to catch up with a double dose. For a broader look at how tirzepatide works and what the clinical evidence shows, the tirzepatide information page is a useful starting point.
Keep a simple log of your injection dates, any side effects, and how you're feeling week by week. It doesn't need to be elaborate, a note in your phone is enough. It makes dose-review conversations with your prescriber considerably more useful, because "I've been a bit off" is harder to act on than "nausea on days one and two after each pen, settling by day three." If you want structured guidance on getting the most from each stage of treatment, our page on Mounjaro tips for weight loss is worth a read alongside your prescriber reviews.
Most side effects in the first weeks are mild and expected. A few require prompt attention. Seek urgent medical help for severe stomach pain that doesn't ease and radiates to the back, this can indicate pancreatitis, which the MHRA highlighted as a known but infrequent risk in a Drug Safety Update published in January 2026. Signs of an allergic reaction (rash, difficulty breathing, swelling of the face or throat), gallbladder-type pain (sharp, upper-right abdomen, possibly with fever), or significant dehydration from persistent vomiting all warrant medical attention the same day. If in doubt, call 111 or your GP.
You can report any suspected side effect via the MHRA Yellow Card scheme, patients can do this directly, not just clinicians. It contributes to the ongoing safety monitoring of newer medicines and is genuinely useful.
If you're weighing up whether Mounjaro is right for you in the first place, or exploring what private treatment involves, our tips for using Mounjaro page can help you feel more confident about what to expect before you begin. The free consultation at nume is a good place to start, your answers go to a GPhC-registered prescriber, not an algorithm, and you'll hear back the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.